Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CVS HEALTH CorpCVS · Entity 2884 | EVP & Chief Operating Officer | April 01, 2022 | April 05, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CVS HEALTH Corp
Report date April 01, 2022 · Filed April 05, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $101.09 · Expires 2032-04-01 | Direct | 25,987 |
Reported balance
After 2022-04-01 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2022-04-01 · Grant · Acquired 25,987 · Balance 25,987 F1: Option becomes exercisable in four equal installments, commencing 4/1/2023. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $104.82 · Expires 2023-04-01 | Direct | 161,318 |
Reported balance
Holding disclosure · report date 2022-04-01 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 161,318 F3: Option became exercisable in four equal annual installments, commencing 4/1/2017. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $78.05 · Expires 2024-04-03 | Direct | 200,358 |
Reported balance
Holding disclosure · report date 2022-04-01 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 200,358 F4: Option became exercisable in four equal annual installments, commencing 4/3/2018. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $62.21 · Expires 2025-04-01 | Direct | 248,131 |
Reported balance
Holding disclosure · report date 2022-04-01 · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · Balance 248,131 F5: Option became exercisable in four equal annual installments, commencing 4/1/2019. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $54.19 · Expires 2029-04-01 | Direct | 303,010 |
Reported balance
Holding disclosure · report date 2022-04-01 · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · Balance 303,010 F6: Option became exercisable in four equal annual installments, commencing 4/1/2020. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $58.34 · Expires 2030-04-01 | Direct | 239,355 |
Reported balance
Holding disclosure · report date 2022-04-01 · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · Balance 239,355 F7: The number of shares subject to the option were calculated using a 30-day average price. F8: Options became exercisable in four equal installments, commencing 4/1/2021. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $74.30 · Expires 2031-04-01 | Direct | 172,772 |
Reported balance
Holding disclosure · report date 2022-04-01 · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · Balance 172,772 F9: Option becomes exercisable in four equal installments, commencing 4/1/2022. |
| Common StockSEC Table I · non-derivative | Direct | 426,024.717 |
Reported balance
Holding disclosure · report date 2022-04-01 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 426,024.717 |
| Common StockSEC Table I · non-derivative | IndirectBy GRAT | 38,192 |
Reported balance
Holding disclosure · report date 2022-04-01 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 38,192 |
| Common Stock (restricted)SEC Table I · non-derivative | Direct | 12,812 |
Reported balance
Holding disclosure · report date 2022-04-01 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 12,812 |
| ESOP Common StockSEC Table I · non-derivative | IndirectBy ESOP | 6,155.5059 |
Reported balance
Holding disclosure · report date 2022-04-01 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 6,155.5059 |
| Stock UnitSEC Table I · non-derivative | Direct | 341,392.3767 |
Reported balance
Holding disclosure · report date 2022-04-01 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 341,392.3767 |
| Phantom Stock CreditsSEC Table II · derivative / convertible security · Conversion / exercise price $1.00 | Direct | 1,416.3128 |
Reported balance
Holding disclosure · report date 2022-04-01 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 1,416.3128 F2: Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person. |
Filing footnotes · ownership attribution and instrument terms
F1: Option becomes exercisable in four equal installments, commencing 4/1/2023.
F2: Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
F3: Option became exercisable in four equal annual installments, commencing 4/1/2017.
F4: Option became exercisable in four equal annual installments, commencing 4/3/2018.
F5: Option became exercisable in four equal annual installments, commencing 4/1/2019.
F6: Option became exercisable in four equal annual installments, commencing 4/1/2020.
F7: The number of shares subject to the option were calculated using a 30-day average price.
F8: Options became exercisable in four equal installments, commencing 4/1/2021.
F9: Option becomes exercisable in four equal installments, commencing 4/1/2022.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 01, 2009 Filed Apr 3, 2009 20:29 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 101,708 | $0.00 Strike: $28.10 | $0.00 |
DisclosureSEC source: 0001127602-09-008781 · form4.xml · derivative · entry 5 Roberts Jonathan C · CIK 0001410515 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,708 Underlying: Common Stock · 101,708 shares Expires 2016-04-01 F1 · derivative.exercise_date: Option becomes exercisable in three equal installments, commencing 4/1/2010. Read SEC document |
| April 01, 2009 Filed Apr 3, 2009 20:29 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 8,452 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-09-008781 · form4.xml · nonDerivative · entry 1 Roberts Jonathan C · CIK 0001410515 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,636 F2 · shares: Consists of Restricted Stock Units awarded pursuant to issuer's 1997 Incentive Compensation Plan. Restrictions lapse on two equal installments 50% on 4/1/2012 and 50% on 04/01/2014. Read SEC document |
| March 03, 2009 Filed Mar 4, 2009 20:09 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 4,461 | $24.60 | $109,740.60 |
DisclosureSEC source: 0001127602-09-005827 · form4.xml · nonDerivative · entry 2 Roberts Jonathan C · CIK 0001410515 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,856.0839 F1 · shares: Surrender of shares in payment of withholding taxes due in connection with a previously reported transaction. Read SEC document |
| February 18, 2009 Filed Feb 20, 2009 21:35 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Unit | 3,424 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-09-004386 · form4.xml · nonDerivative · entry 1 Roberts Jonathan C · CIK 0001410515 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,424 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 1997 Incentive Compensation Plan, the receipt of which the reporting person has elected to defer. Read SEC document |
| February 13, 2009 Filed Mar 4, 2009 20:09 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 650 | $27.47 | $17,855.50 |
DisclosureSEC source: 0001127602-09-005827 · form4.xml · nonDerivative · entry 1 Roberts Jonathan C · CIK 0001410515 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,317.0839 F1 · shares: Surrender of shares in payment of withholding taxes due in connection with a previously reported transaction. Read SEC document |
| April 01, 2008 Filed Apr 3, 2008 20:31 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 86,487 | $0.00 Strike: $41.17 | $0.00 |
DisclosureSEC source: 0000064803-08-000047 · doc.xml · derivative · entry 14 Roberts Jonathan C · CIK 0001410515 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,487 Underlying: Common Stock · 86,487 shares Expires 2015-04-01 F4 · derivative.exercise_date: Option becomes exercisable in three equal annual installments, commencing 4/1/2009. Read SEC document |
| April 01, 2008 Filed Apr 3, 2008 20:31 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (Restricted) | 6,073 | $0.00 | $0.00 |
DisclosureSEC source: 0000064803-08-000047 · doc.xml · nonDerivative · entry 3 Roberts Jonathan C · CIK 0001410515 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,873 F2 · shares: Consists of Restricted Stock Units awarded pursuant to issuer's 1997 Incentive Compensation Plan. Restrictions lapse on two equal installments 50% on 04/01/2011 and 50% on 04/01/2013. Read SEC document |
| April 01, 2008 Filed Apr 3, 2008 20:31 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (Restricted) | 12,145 | $0.00 | $0.00 |
DisclosureSEC source: 0000064803-08-000047 · doc.xml · nonDerivative · entry 2 Roberts Jonathan C · CIK 0001410515 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,800 F1 · shares: Consists of Restricted Stock Units awarded pursuant to issuer's 1997 Incentive Compensation Plan. Restrictions lapse on 04/01/2013. Read SEC document |
| February 15, 2008 Filed Mar 6, 2008 21:32 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 1,254 | $39.72 | $49,808.88 |
DisclosureSEC source: 0000064803-08-000037 · doc.xml · nonDerivative · entry 1 Roberts Jonathan C · CIK 0001410515 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,242 Read SEC document |
| December 18, 2007 Filed Feb 4, 2008 21:33 UTC | CVS HEALTH Corp CVS · Entity 2884 | GiftCommon Stock | 2,500 | $39.14 | $97,850.00 |
DisclosureSEC source: 0000064803-08-000011 · doc.xml · nonDerivative · entry 1 Roberts Jonathan C · CIK 0001410515 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,605 Read SEC document |
| August 30, 2007 Filed Sep 4, 2007 21:14 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 40,000 | $0.00 Strike: $18.66 | $0.00 |
DisclosureSEC source: 0000064803-07-000145 · doc.xml · derivative · entry 18 Roberts Jonathan C · CIK 0001410515 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 40,000 shares Expires 2008-03-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Option became exercisable in three annual installments, commencing 03/12/01. Read SEC document |
| August 30, 2007 Filed Sep 4, 2007 21:14 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 13,020 | $0.00 Strike: $18.35 | $0.00 |
DisclosureSEC source: 0000064803-07-000145 · doc.xml · derivative · entry 17 Roberts Jonathan C · CIK 0001410515 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,020 shares Expires 2008-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option became exercisable in three annual installments, commencing 02/27/01. Read SEC document |
| August 30, 2007 Filed Sep 4, 2007 21:14 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 54,000 | $0.00 Strike: $12.56 | $0.00 |
DisclosureSEC source: 0000064803-07-000145 · doc.xml · derivative · entry 16 Roberts Jonathan C · CIK 0001410515 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 54,000 shares Expires 2013-01-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option became exercisable in three annual installments, commencing 1/9/2005. Read SEC document |
| August 30, 2007 Filed Sep 4, 2007 21:14 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 107,020 | $37.58 | $4,021,940.02 |
DisclosureSEC source: 0000064803-07-000145 · doc.xml · nonDerivative · entry 4 Roberts Jonathan C · CIK 0001410515 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,105 Read SEC document |
| August 30, 2007 Filed Sep 4, 2007 21:14 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 40,000 | $18.66 | $746,252.00 |
DisclosureSEC source: 0000064803-07-000145 · doc.xml · nonDerivative · entry 3 Roberts Jonathan C · CIK 0001410515 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,125 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 30, 2007 Filed Sep 4, 2007 21:14 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 13,020 | $18.35 | $238,887.05 |
DisclosureSEC source: 0000064803-07-000145 · doc.xml · nonDerivative · entry 2 Roberts Jonathan C · CIK 0001410515 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,125 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 30, 2007 Filed Sep 4, 2007 21:14 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 54,000 | $12.56 | $678,375.00 |
DisclosureSEC source: 0000064803-07-000145 · doc.xml · nonDerivative · entry 1 Roberts Jonathan C · CIK 0001410515 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,105 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.